Pacira BioSciences Inc - Company Profile
Powered by 
All the data and insights you need on Pacira BioSciences Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Pacira BioSciences Inc Strategy Report
- Understand Pacira BioSciences Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Business Description
Pacira BioSciences Inc (Pacira) is a provider of non-opioid pain management and regenerative health solutions. It focuses on the clinical and commercial development of products that meet the needs of acute care practitioners and their patients. It develops products based on its proprietary DepoFoam drug delivery technology for the use in hospitals and ambulatory surgery centers.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
R&D Overview
Pacira focuses to develop innovative products through its major technologies including DepoFoam delivery technology. In FY2022, the company spent US$84.7 million on its R&D activities, which as a percentage of revenue stood at 12.7%. As of December 2022, the company had more than 13 families of patents and patent applications related to DepoFoam delivery technology; and 29 families of patents and patent applications related to the technology used by iovera. Its pipeline products include: PCRX-201, a novel gene therapy product for the treatment of OA pain in the knee, in Phase I clinical trials; PCRX-401, PCRX-501, EXPAREL are in pre-clinical trials for the treatment of pain.
Product Categories
Overview
Bupivacaine liposome injectable suspension is an amide-type local anesthetic, encapsulated in pMVL drug delivery technology, which delivers bupivacaine overtime for extended analgesia.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Overview
Exparel is a liposome injection of bupivacaine, an amide-type local anesthetic. It is a long-acting non-opioid postsurgical analgesic indicated for infiltration into the surgical site to produce postsurgical analgesia for up to 72 hours. It also conducts six clinical trials of Exparel in various therapeutic areas such as spine, C-section, lower extremity nerve block and pediatric nerve block.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Overview
iovera is a non-opioid handheld cryoanalgesia device used to produce precise, controlled doses of cold temperature only to targeted nerves.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Overview
Zilretta is an extended-release, intra-articular, corticosteroid injection targeted for the management of OA knee pain.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer